Table 1 Characteristics of the patients included in the ancillary study of the ROC trial
Characteristics | TNFi | Non-TNFi biologic | Total |
|---|---|---|---|
Number of women (%) | 114 (85.7) | 110 (82.1) | 224 (83.9) |
Mean age (SD) | 55.9 (13.0) | 58.4 (11.2) | 57.2 (12.1) |
Number rheumatoid factor-positive (%) | 108 (82.4) | 101 (76.5) | 209 (79.8) |
Number anti-CCP-positive (%) | 102 (79.7) | 105 (82.7) | 207 (81.2) |
Mean DAS28-CRP (SD) | 4.7 (0.9) | 4.8 (1.1) | 4.8 (1.0) |